Skip to main content

Animations

MJFF Publications

5561 - 5570 of 9145 Results
Title
Year
  • Year
  • 2013
  • 2013
  • 2013
  • 2019
  • 2018
  • 2020
  • 2021
  • 1967
  • 2019
  • 2020
  • Announcing a New Continuing Medical Education Course
    2013
    Summary Details
    RESTRICTED
    Title: Announcing a New Continuing Medical Education Course
    Journal Name: Cognitive and Behavioral Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/wnn.0b013e31829af2fb
    Citation Count: 1
  • The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)
    2013
    Summary Details
    RESTRICTED
    Title: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049
    Citation Count: 2
  • P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease
    2013
    Summary Details
    RESTRICTED
    Title: P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease
    Journal Name: Neuromuscular Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nmd.2013.06.684
    Citation Count: 1
  • NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)
    2019
    Summary Details
    RESTRICTED
    Title: NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-035
    Citation Count: 2
  • At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease
    2018
    Summary Details
    OPEN
    Title: At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27310
    Citation Count: 1
  • Validation of Fox Insight Cohort via Virtual Research Visits (4749)
    2020
    Summary Details
    RESTRICTED
    Title: Validation of Fox Insight Cohort via Virtual Research Visits (4749)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4749
    Citation Count: 1
  • Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
    2021
    Summary Details
    RESTRICTED
    Title: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
    Journal Name: Physiology News
    Publisher: The Physiological Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.36866/pn.123.32
    Citation Count: 1
  • The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA
    1967
    Summary Details
    RESTRICTED
    Title: The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA
    Journal Name: Arthritis & Rheumatism
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/art.1780100105
    Citation Count: 45
  • Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)
    2019
    Summary Details
    RESTRICTED
    Title: Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-010
    Citation Count: 1
  • Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    2020
    Summary Details
    RESTRICTED
    Title: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.